SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura

Blood. 2022 Apr 21;139(16):2570-2573. doi: 10.1182/blood.2022015545.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS13 Protein
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic*
  • Purpura, Thrombotic Thrombocytopenic*
  • SARS-CoV-2
  • Thrombosis*
  • Vaccination

Substances

  • COVID-19 Vaccines
  • ADAMTS13 Protein